Apellis Pharmaceuticals (APLS) PT Lowered to $38 at Mizuho
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Mizuho analyst Graig Suvannavejh lowered the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $38.00 (from $39.00) while maintaining a Neutral rating.
You May Also Be Interested In
- TerraVest Industries Inc (TVK:CN) PT Raised to Cdn$170 at BMO Capital
- Ascendis Pharma (ASND) PT Raised to $290 at RBC Capital
- Netskope (NTSK) PT Raised to $18 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
